$1.040
+0.042 (+4.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CVKD Prediction & Forecast by Similar Chart Analysis
Alphio's CVKD stock price prediction model matches the current Cadrenal Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.00 (-4.09%). The 1-week path is $1.01 (-2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cadrenal Therapeutics Inc Stock?
Cadrenal Therapeutics Inc (CVKD) is currently trading at $1.04, which is significantly lower than its 52-week high of $13.01, indicating a potential for recovery. However, the stock has a low RSI of 43.865, suggesting it is not yet oversold, and the forward P/E ratio is at 0, indicating uncertainty in future earnings. The recent positive news about a $3 million private placement and a 25% reduction in thrombotic events from CAD-1005 are encouraging signs, but the company has a substantial year-to-date decline of 85.81% and negative net income figures, with the latest reported EPS at -1.14. Therefore, while there are some positive catalysts, the overall financial performance and significant risks suggest a hold position for now.
CVKD stock price ended at $1.04 on Friday, after rising +4.00%
Cadrenal Therapeutics Inc (CVKD) last closed at $1.04, gaining +4.00%. These facts feed the 1-day and 1-week CVKD price prediction above.
Forecast Drivers
Cadrenal Therapeutics Inc (CVKD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CVKD, ranked by similarity.
Seasonality analysis for CVKD
Historically the probability of a positive November return for CVKD is 45.45%. January offers the highest probability of a positive month at 75.41%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CVKD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $8.95 | $10.19 | $10.29 | +879.67% |
| Dec 2026 | $11.65 | $12.26 | $12.79 | +1078.89% |
In 2026, Cadrenal Therapeutics Inc (CVKD) is projected to range from $8.95 to $12.79.
Cadrenal Therapeutics Inc 2026 monthly forecast
In Nov 2026, Cadrenal Therapeutics Inc is projected to average $10.19, with a low of $8.95 and high of $10.29.
In Dec 2026, Cadrenal Therapeutics Inc is projected to average $12.26, with a low of $11.65 and high of $12.79.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.